List view / Grid view

Dr Gordon Baxter

 

article

Target safety assessments – identifying risk early

With an ever-increasing emphasis on minimising drug candidate attrition, scientists…

18 November 2021 | By

With an ever-increasing emphasis on minimising drug candidate attrition, scientists are focusing on target safety at earlier points in the research process. In this exclusive interview, Drug Target Review spoke with Dr Gordon Baxter, Chief Scientific Officer of Instem, to learn how target safety assessments can enable researchers to quickly…